The post-COVID-19 market moves fast. Many products in biotechnology rely on the quick and flexible production of high-quality oligonucleotides such as primers, probes, NGS adaptors, SCORPIONS and more. In this webinar, we give you an insider’s look at the production of oligos for commercial and bulk supply by QIAGEN DNA Synthesis, including what we offer, our customization capabilities and our flexibility to scale production according to your needs. In addition, we introduce QIAGEN Strategic Partnerships & OEM, which offers access to our nearly 40 years of industry-leading experience in a tight working relationship.

We look forward to meeting you at the webinar. Let’s accelerate your innovation, together.